hsa-mir-605-5p _CESC.png
hsa-mir-372-3p _CESC.png
hsa-mir-1246 _CESC.png
hsa-mir-4524a-3p _CESC.png
hsa-mir-1197 _CESC.png
hsa-mir-6769b-5p _CESC.png
hsa-mir-19a-3p _CESC.png
hsa-mir-331-3p _CESC.png
hsa-mir-21-5p _CESC.png
NFIB _CESC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS20000092
Fusion event
HPV-NFIB integration
Validated
Yes
Detection method
PCR and Sanger sequencing
Data source
Curated
Sample type
Disease
Cervical carcinoma (CC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HPV
Subtype
HPV16
Reference genome
Region type
E6
Start
551
Integrated sequence
ATGAGACTGAAACACCATGTAGTCAGTATAGTGGTGGAAGTGGGGGTGGTTGCAGTCAGTACAGTAGTGGAAGTGGGGGAGAGGGTGTTAGTGAAAGACA| |CACTATATGCCAAACACCACTTACAAATATTTTAAATGTACTAAAAACTAGTAATGCAAAGGCAGCAATGTTAGCAAAATTTAAAGAGTTATACGGGGTG
Host Sequence
Chromosome
chr9
Cytoband
p22.3
Reference genome
End
14275445/14275446 (Hg38)
Location type
Intronic
Target gene
miRNAs that regulate target gene
hsa-mir-21-5p ; hsa-mir-372-3p ; hsa-mir-373-3p ; hsa-mir-130b-3p ; hsa-mir-124-3p ; hsa-mir-192-5p ; hsa-mir-93-5p ; hsa-mir-19b-3p ; hsa-mir-92a-3p ; hsa-mir-548c-3p ; hsa-mir-4668-3p ; hsa-mir-1277-5p ; hsa-mir-590-3p ; hsa-mir-19a-3p ; hsa-mir-130a-3p ; hsa-mir-301a-3p ; hsa-mir-519c-3p ; hsa-mir-519b-3p ; hsa-mir-519a-3p ; hsa-mir-454-3p ; hsa-mir-301b-3p ; hsa-mir-4295 ; hsa-mir-3666 ; hsa-mir-5011-5p ; hsa-mir-3714 ; hsa-mir-548aw ; hsa-mir-190a-3p ; hsa-mir-335-3p ; hsa-mir-8059 ; hsa-mir-4471 ; hsa-mir-1468-3p ; hsa-mir-548x-5p ; hsa-mir-548g-5p ; hsa-mir-548f-5p ; hsa-mir-548aj-5p ; hsa-mir-4517 ; hsa-mir-605-3p ; hsa-mir-20b-5p ; hsa-mir-519d-3p ; hsa-mir-526b-3p ; hsa-mir-17-5p ; hsa-mir-106b-5p ; hsa-mir-106a-5p ; hsa-mir-20a-5p ; hsa-mir-6857-5p ; hsa-mir-491-5p ; hsa-mir-6769b-5p ; hsa-mir-6769a-5p ; hsa-mir-92a-2-5p ; hsa-mir-654-5p ; hsa-mir-541-3p ; hsa-mir-4451 ; hsa-mir-379-5p ; hsa-mir-3529-5p ; hsa-mir-4650-3p ; hsa-mir-4450 ; hsa-mir-3134 ; hsa-mir-6134 ; hsa-mir-1197 ; hsa-mir-6757-3p ; hsa-mir-3924 ; hsa-mir-656-3p ; hsa-mir-4775 ; hsa-mir-512-3p ; hsa-mir-4803 ; hsa-mir-302d-3p ; hsa-mir-302c-3p ; hsa-mir-302a-3p ; hsa-mir-302b-3p ; hsa-mir-302e ; hsa-mir-520b ; hsa-mir-520a-3p ; hsa-mir-520e ; hsa-mir-520d-3p ; hsa-mir-520c-3p ; hsa-mir-3912-5p ; hsa-mir-6748-3p ; hsa-mir-331-3p ; hsa-mir-6810-3p ; hsa-mir-6801-3p ; hsa-mir-605-5p ; hsa-mir-339-5p ; hsa-mir-6876-3p ; hsa-mir-626 ; hsa-mir-6773-3p ; hsa-mir-6893-3p ; hsa-mir-370-3p ; hsa-mir-1228-3p ; hsa-mir-3185 ; hsa-mir-1246 ; hsa-mir-129-5p ; hsa-mir-3672 ; hsa-mir-4524a-3p ; hsa-mir-6864-3p ; hsa-mir-8055 ; hsa-mir-431-5p ; hsa-mir-5691 ; hsa-mir-624-3p ; hsa-mir-6805-3p
Nearest miRNA
hsa-mir-101-2/Upstream/8267542; hsa-let-7a-1/Downstream/4297860;
Nearest cancer related gene
NFIB(OG, No orient, 0)
Upstream sequence
cggcgggccgccccgccgtgcgccgggaccggggtccggggcggagtgcccttcctcctgggaaacggggtgcggccggaaaggcggccgccccctcgcc
Downstream sequence
aaaatgggcaatatcattaatgtttaaaaattggttaagttgtaacatagccacaaaacggatactatgacaccaccaaaaattatgATAATGATTaatg
Reference
Liu, Y., et al. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget,2016, 7(5): 5852-5864.
Curate